Dr. Sanjay Multispeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 02-01-2025
- Paid Up Capital ₹ 5.10 M
as on 02-01-2025
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.74 M
as on 02-01-2025
- Revenue 1.40%
(FY 2021)
- Profit 42.77%
(FY 2021)
- Ebitda 0.63%
(FY 2021)
- Net Worth 10.23%
(FY 2021)
- Total Assets 20.27%
(FY 2021)
About Dr. Sanjay Multispeciality Hospital
The Corporate was formerly known as Sams Biotech Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 5.10 M.
The company currently has active open charges totaling ₹2.74 M.
Sanjay Singh and Poonam Singh serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC203581
- Company No.
203581
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Sanjay Multispeciality Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Singh  | Director | 03-Jun-2010 | Current |
| Poonam Singh | Director | 15-Jul-2014 | Current |
Financial Performance of Dr. Sanjay Multispeciality Hospital.
Dr. Sanjay Multispeciality Hospital Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 1.4% increase. The company also saw a substantial improvement in profitability, with a 42.77% increase in profit. The company's net worth Soared by an impressive increase of 10.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Sanjay Multispeciality Hospital?
In 2021, Dr. Sanjay Multispeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bahadurgarh Diagnostics Centre Private LimitedActive 3 years 1 monthPoonam Singh is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 03 Feb 2022 | ₹1.49 M | Open |
Others Creation Date: 01 Jun 2017 | ₹1.25 M | Open |
How Many Employees Work at Dr. Sanjay Multispeciality Hospital?
Dr. Sanjay Multispeciality Hospital has a workforce of 6 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Sanjay Multispeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Sanjay Multispeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
